175 related articles for article (PubMed ID: 23510884)
1. FDG PET/CT in serous psammocarcinoma of the ovary.
Dong A; Wang Y; Zuo C
Clin Nucl Med; 2014 May; 39(5):453-5. PubMed ID: 23510884
[TBL] [Abstract][Full Text] [Related]
2. Serous psammocarcinoma of the ovary: CT and MR findings.
Hiromura T; Tanaka YO; Nishioka T; Tomita K
J Comput Assist Tomogr; 2007; 31(3):490-2. PubMed ID: 17538302
[TBL] [Abstract][Full Text] [Related]
3. Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancer.
Cohn DE; Hall NC; Povoski SP; Seamon LG; Farrar WB; Martin EW
Gynecol Oncol; 2008 Aug; 110(2):152-7. PubMed ID: 18539314
[TBL] [Abstract][Full Text] [Related]
4. Calcified metastases from ovarian carcinoma highlighted by F-18 FDG PET/CT: report of two cases.
Hu SL; Zhou ZR; Zhang YJ
Abdom Imaging; 2012 Aug; 37(4):675-9. PubMed ID: 21898082
[TBL] [Abstract][Full Text] [Related]
5. FDG-PET/CT as a molecular biomarker in ovarian cancer.
Nowosinska E; Avril S; Murray I; Szyszko T; Avril N
Cancer Biomark; 2010-2011; 8(4-5):167-75. PubMed ID: 22045351
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT of a benign ovarian Brenner tumor.
Toriihara A; Taniguchi Y; Negi M; Kubota K; Makino T; Shibuya H
Clin Imaging; 2012; 36(5):650-3. PubMed ID: 22920385
[TBL] [Abstract][Full Text] [Related]
7. Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary.
Kurokawa T; Yoshida Y; Kawahara K; Tsuchida T; Okazawa H; Fujibayashi Y; Yonekura Y; Kotsuji F
Int J Cancer; 2004 May; 109(6):926-32. PubMed ID: 15027127
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoma of the ovary: additional role of 18F-FDG PET/CT.
Santhosh S; Mittal BR; Raveendran A; Jain V; Nijhawan R; Kumar R; Bhattacharya A; Sharma SC
Clin Nucl Med; 2013 May; 38(5):e230-2. PubMed ID: 23377413
[TBL] [Abstract][Full Text] [Related]
9. Bilateral ovarian metastases from gastric carcinoma on FDG PET/CT.
Ho L; Wassef H; Nakla A; Henderson R
Clin Nucl Med; 2012 May; 37(5):524-7. PubMed ID: 22475913
[TBL] [Abstract][Full Text] [Related]
10. Assessment of ovarian teratoma and lymphadenopathy by 18F-FDG PET/CT.
Balink H; Apperloo MJ; Collins J
Clin Nucl Med; 2012 Aug; 37(8):804-6. PubMed ID: 22785518
[TBL] [Abstract][Full Text] [Related]
11. Physiologic FDG uptake in the ovary together with an abdominal wall leiomyoma mimicking metastasizing ovarian cancer on PET/CT imaging.
Schwarz EI; Ramach C; Mende KA; Strobel K
Clin Nucl Med; 2009 Apr; 34(4):249-50. PubMed ID: 19300062
[TBL] [Abstract][Full Text] [Related]
12. Serous psammocarcinoma of the ovary: a case report and review of literature.
Giordano G; Gnetti L; Milione M; Piccolo D; Soliani P
Gynecol Oncol; 2005 Jan; 96(1):259-62. PubMed ID: 15589614
[TBL] [Abstract][Full Text] [Related]
13. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
14. [18F-FDG PET/CT in patients, treated for ovarian cancer, with elevated CA 125 levels but no evidence of recurrence on conventional imaging].
Bochev P; Bocheva Y; Klisarova A; Ivanov S; Dancheva J; Chaushev B
Akush Ginekol (Sofiia); 2012; 51(1):18-27. PubMed ID: 22639775
[No Abstract] [Full Text] [Related]
15. Impact of positron emission tomography/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment.
Nasu K; Abe W; Takai N; Tomonari K; Narahara H
Arch Gynecol Obstet; 2011 May; 283(5):1121-6. PubMed ID: 20574659
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m diphosphonate imaging of psammocarcinoma of probable ovarian origin: case report and literature review.
Radin AI; Youssef IM; Quimbo RD; Perone RW; Guerrieri C; Abdel-Dayem HM
Clin Nucl Med; 2005 Jun; 30(6):395-9. PubMed ID: 15891291
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT for diagnosis of primary ovarian cancer.
Kitajima K; Suzuki K; Senda M; Kita M; Nakamoto Y; Onishi Y; Maeda T; Yoshikawa T; Ohno Y; Sugimura K
Nucl Med Commun; 2011 Jul; 32(7):549-53. PubMed ID: 21407140
[TBL] [Abstract][Full Text] [Related]
18. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
19. Unilateral ovarian metastasis from gastric mucinous adenocarcinoma visualized on FDG PET/CT.
Tamam MO; Mulazimoglu M; Kamali G; Eker O; Ozpacaci T
Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():1-3. PubMed ID: 23090794
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.
De Iaco P; Musto A; Orazi L; Zamagni C; Rosati M; Allegri V; Cacciari N; Al-Nahhas A; Rubello D; Venturoli S; Fanti S
Eur J Radiol; 2011 Nov; 80(2):e98-103. PubMed ID: 20688446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
